Nucliq Test Focuses on Gut Microbiome and Women’s Health

St. John’s-based gene sequencing firm Nucliq Biologics is launching a new product that measures how a woman’s gut microbiome influences her hormonal health.
The new product, launching May 14 at innovation hub Genesis, is called GutCheckVivo. It follows the success of Nucliq’s first product GutCheck, which assesses an individual’s gut microbiome and advises clients on how to address any issues,